Completed PHASE3 INTERVENTIONAL 2-arm NCT01968408

Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children

Effectiveness of Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children: a Randomized, Double-blind Placebo Controlled Trial

Sponsor: Medical University of Warsaw

Conditions Diarrhea

Interventions Lactobacillus reuteri DSM 17938 Placebo

Updated 5 times since 2017 Last updated: Jun 17, 2015 Started: Sep 30, 2012 Primary completion: Feb 28, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Diarrhea and is currently completed. Medical University of Warsaw leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Warsaw

Data source: Medical University of Warsaw

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland